---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-226828"
form_type: "8-K"
ticker: "ENTA"
cik: "0001177648"
company_name: "ENANTA PHARMACEUTICALS INC"
filed_at: "2025-10-01T23:59:59+00:00"
generated_at: "2026-05-17T05:03:05.564574+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Enanta Pharmaceuticals prices public offering of 6.5M shares at $10/share, expects ~$60.6M net proceeds

## Summary
- 6,500,000 shares offered at $10.00 per share; underwriters have 30-day option for 975,000 more shares.
- Expected net proceeds of approximately $60.6 million after underwriting discounts and offering expenses.
- Offering expected to close on October 2, 2025, subject to customary closing conditions.
- Underwriting agreement with J.P. Morgan, Jefferies, and Evercore dated September 30, 2025.

## SEC filing metadata
- accession: 0001193125-25-226828
- form_type: 8-K
- ticker: ENTA
- cik: 0001177648
- company_name: ENANTA PHARMACEUTICALS INC
- filed_at: 2025-10-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1177648/000119312525226828/0001193125-25-226828-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1177648/000119312525226828/d81869d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-226828
- JSON: https://secwatch.observer/filing/0001193125-25-226828.json
- Plain text: https://secwatch.observer/filing/0001193125-25-226828.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.